Anagrelide(Xagrid)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of
a
pharmacist. For read by medical and pharmaceutical professionals only.
Xagrid(Anagrelide) Instructions:Uses,Dosage, Side Effects
AGRYLIN is indicated specifically for managing thrombocythemia (elevated platelet count) that is secondary to underlying myeloproliferative neoplasms. These conditions include Essential Thrombocythemia (ET), Polycythemia Vera (PV), and Chronic Myelogenous Leukemia (CML).
The treatment aims to reduce the high platelet count, thereby lowering the associated risk of thrombotic events and ameliorating related thrombo-hemorrhagic symptoms.
Generic name
Anagrelide(Xagrid)
Indications
Treatment of thrombocythemia, secondary to myeloproliferative neoplasms (e.g., Essential Thrombocythemia, Polycythemia Vera), to reduce the elevated platelet count, the risk of thrombosis, and to ameliorate associated thrombo-hemorrhagic symptoms.
Therapeutic Target
The precise mechanism is not fully elucidated, but it suppresses megakaryocytopoiesis, reducing platelet production. It is also a phosphodiesterase 3 (PDE3) inhibitor.
Active Ingredients
Anagrelide
specifications
0.5mg * 100 tablets/capsules
Dosage and Administration
Recommended starting dose is 0.5 mg four times daily or 1 mg twice daily.
RELATED ARTICLES
How to Use Anagrelide (Agrylin)
Anagrelide (Agrylin) is a selective thrombocytopenic agent primarily used to treat thrombocythemia secondary to...
Monday, October 13th, 2025, 14:33
Indications for Anagrelide (Agrylin)
Anagrelide (Agrylin) is a thrombocytopenic agent primarily indicated for the treatment of thrombocythemia caused by...
Wednesday, September 24th, 2025, 14:22
Contact Us
Mailbox:Info@Lucius.La
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved